AtriCure, Inc. — Director's Dealing 2017

Jun 15, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2017-06-13

Reporting Person: Seith Douglas J (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-13	Common Stock	M	1500	$10.10	Acquired	240979	Direct
2017-06-13	Common Stock	M	10000	$10.05	Acquired	250979	Direct
2017-06-13	Common Stock	M	512	$5.70	Acquired	251491	Direct
2017-06-13	Common Stock	M	21100	$6.27	Acquired	272591	Direct
2017-06-13	Common Stock	M	25000	$6.73	Acquired	297591	Direct
2017-06-13	Common Stock	S	58112	$21.39	Disposed	239479	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-13	Stock Option (right to buy)	$10.10	M	1500	Disposed	2018-05-28	Common Stock (1500)	Direct
2017-06-13	Stock Option (right to buy)	$10.05	M	10000	Disposed	2018-07-30	Common Stock (10000)	Direct
2017-06-13	Stock Option (right to buy)	$5.70	M	512	Disposed	2018-10-28	Common Stock (512)	Direct
2017-06-13	Stock Option (right to buy)	$6.27	M	21100	Disposed	2022-10-25	Common Stock (21100)	Direct
2017-06-13	Stock Option (right to buy)	$6.73	M	25000	Disposed	2022-12-27	Common Stock (25000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3500	Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $21.08 to $21.65 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.

F3: These options were granted on May 28, 2008 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.

F4: These options were granted on July 30, 2008 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.

F5: These options were granted on October 28, 2008 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.

F6: These options were granted on October 25, 2012 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.

F7: These options were granted on December 27, 2012 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.